A gradient deployment of more than 10 hypertension products/projects has been developed, fully covering the treatment needs of hypertension and continuously consolidating our leading position in the domestic hypertension market. Based on a profound understanding of the disease pathogenesis and clinical symptoms, we have comprehensively covered all innovative drug targets for heart failure, aiming to build the most competitive product pipeline for chronic heart failure in China.
